Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Cardinal Health, Inc.    CAH

CARDINAL HEALTH, INC.

(CAH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/11/2020 09/14/2020 09/15/2020 09/16/2020 09/17/2020 Date
48.38(c) 47.05(c) 46.55(c) 47.21(c) 47.3(c) Last
1 481 044 4 552 093 2 600 277 4 038 243 3 926 799 Volume
-0.33% -2.75% -1.06% +1.42% +0.19% Change
More quotes
Financials (USD)
Sales 2021 160 B - -
Net income 2021 1 268 M - -
Net Debt 2021 2 975 M - -
P/E ratio 2021 11,6x
Yield 2021 4,21%
Sales 2022 167 B - -
Net income 2022 1 355 M - -
Net Debt 2022 1 846 M - -
P/E ratio 2022 10,5x
Yield 2022 4,34%
Capitalization 13 833 M 13 833 M -
EV / Sales 2021 0,11x
EV / Sales 2022 0,09x
Nbr of Employees 48 000
Free-Float 89,4%
More Financials
Company
Cardinal Health is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (88.6%); - distribution of medical, surgical and laboratory products (11.4%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic... 
Sector
Drug Retailers
Calendar
09/30Ex-dividend day for
More about the company
Notations Surperformance© of Cardinal Health, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about CARDINAL HEALTH, INC.
08/31CARDINAL HEALTH INC : Change in Directors or Principal Officers, Regulation FD D..
AQ
08/19States Press Opioid Litigation -- WSJ
DJ
08/18Health Care Flat As Opioid Lawsuit Settlements Loom -- Health Care Roundup
DJ
08/18States Seek $26.4 Billion From Drug Companies in Opioid Litigation
DJ
08/18U.S. States Seek $26.4 Bln From Drug Companies In Opioid Litigation - WSJ
RE
08/07CARDINAL HEALTH : PHARMAC - Decision to list medical devices supplied by Cardina..
AQ
08/06CARDINAL : Fiscal 4Q Earnings Snapshot
AQ
08/06CARDINAL HEALTH INC : Results of Operations and Financial Condition (form 8-K)
AQ
08/06CARDINAL HEALTH : Reports Fourth Quarter and Full Year Results for Fiscal Year 2..
PR
07/06CARDINAL HEALTH : PHARMAC - Proposal to list medical devices supplied by Cardina..
AQ
07/02CARDINAL HEALTH : to Webcast Discussion of Fourth-Quarter and Year-End Results f..
PR
06/30CARDINAL HEALTH, INC. : Ex-dividend day for
FA
06/26CARDINAL HEALTH INC : Change in Directors or Principal Officers (form 8-K)
AQ
06/26CARDINAL HEALTH : Dave Evans to join Cardinal Health Board of Directors
PR
06/11AMERICAN SOFTWARE : Logility Sponsors IBF Town Hall on Forecasting and Planning ..
AQ
More news
News in other languages on CARDINAL HEALTH, INC.
08/18WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
03/06Ramelow stimmte für AfD-Landtagsvize - Parlamentsrechte wahren
02/27AKTIE IM FOKUS 2 : Vorsichtiger Ausblick und schwacher Markt setzen Bayer zu
02/21Daimler met en garde contre les conséquences du coronavirus
02/18RENAULT : Bercy met en garde Renault contre les suppressions d'emplois
More news
Analyst Recommendations on CARDINAL HEALTH, INC.
More recommendations
Chart CARDINAL HEALTH, INC.
Duration : Period :
Cardinal Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARDINAL HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 59,25 $
Last Close Price 47,30 $
Spread / Highest target 39,5%
Spread / Average Target 25,3%
Spread / Lowest Target 5,71%
EPS Revisions
Managers
NameTitle
Michael C. Kaufmann Chief Executive Officer & Director
Gregory B. Kenny Independent Non-Executive Chairman
Jason M. Hollar Chief Financial Officer
Brian S. Rice Chief Information Officer & Executive VP
J. Michael Losh Independent Director
Sector and Competitors